Securian Asset Management Inc. Cuts Holdings in Cardinal Health, Inc. $CAH

Securian Asset Management Inc. reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 43.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,448 shares of the company’s stock after selling 4,995 shares during the quarter. Securian Asset Management Inc.’s holdings in Cardinal Health were worth $1,325,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. NewEdge Wealth LLC increased its position in shares of Cardinal Health by 48.1% during the fourth quarter. NewEdge Wealth LLC now owns 3,354 shares of the company’s stock worth $689,000 after purchasing an additional 1,090 shares in the last quarter. Crossmark Global Holdings Inc. boosted its position in shares of Cardinal Health by 3.5% in the 4th quarter. Crossmark Global Holdings Inc. now owns 62,051 shares of the company’s stock worth $12,751,000 after purchasing an additional 2,095 shares in the last quarter. Ethic Inc. grew its stake in Cardinal Health by 5.4% during the 4th quarter. Ethic Inc. now owns 12,398 shares of the company’s stock worth $2,548,000 after buying an additional 637 shares during the last quarter. Ballentine Partners LLC increased its position in Cardinal Health by 1.0% during the 4th quarter. Ballentine Partners LLC now owns 5,962 shares of the company’s stock valued at $1,225,000 after buying an additional 58 shares in the last quarter. Finally, GRIMES & Co WEALTH MANAGEMENT LLC boosted its holdings in Cardinal Health by 30.5% in the fourth quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 6,777 shares of the company’s stock worth $1,393,000 after acquiring an additional 1,585 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.1%

CAH opened at $182.62 on Wednesday. The firm has a market cap of $42.77 billion, a P/E ratio of 27.92, a P/E/G ratio of 1.08 and a beta of 0.53. The business has a fifty day simple moving average of $209.05 and a 200-day simple moving average of $207.46. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.1%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s payout ratio is 31.19%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of research analyst reports. Jefferies Financial Group boosted their price objective on shares of Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, January 22nd. Morgan Stanley increased their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Leerink Partners reiterated an “outperform” rating and issued a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. Citigroup dropped their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Finally, Evercore dropped their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.